AMY FONTENOT: Open Payments
NPI 1427365105 · VILLE PLATTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 36 payments from 14 companies in 2025. Trend: 2023 $500 · 2024 $739 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $146 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| PFIZER INC. | 3 | $52 |
| Novo Nordisk Inc | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| ConvaTec Inc. | 1 | $18 |
Products named: GEMTESA, Auvelity, TRELEGY ELLIPTA, ELIQUIS, Kerendia, MOUNJARO, FARXIGA, RELISTOR.
Industry payments across LA — which companies pay providers there.
